Nov. 4, 2011 - According to TheGuardian.U.K.The NHS is about to trial a program called "Aire"Transhuman".Artificial Intelligence ToolsThe tool is capable of predicting a patient's risk of disease and premature death.
The program, known asAIA new technology called AI-ECG risk estimation, or Aire for short, is trained to read the results of electrocardiogram (ECG) tests,...Ability to detect underlying structural heart problems that doctors cannot see, and flagged patients who may need further monitoring, testing, or treatment. The researchers reportedly trained Aire using a dataset of 1.16 million ECG test results from 189,539 patients.
It is understood that the technology will be trialed at two NHS trust hospitals in London in the middle of next year, and experts hope it will be rolled out across the healthcare system within the next five years. It is understood thatHundreds of patients will be recruited initially and then scaled up for further studies.
The study, published in the journal The Lancet Digital Health, found thatIn the case of 78%, Aire was able to correctly identify the patient's risk of death within 10 years of ECG examination. In addition, Aire has an accuracy of 761 TP3T in predicting future severe heart rhythm problems and 701 TP3T in predicting future atherosclerotic cardiovascular disease.
Arunahis Sau, a cardiology registrar at Imperial College NHS Trust, who took part in the trial, said the goal of the program was not to replace doctors, but to "outperform humans" through AI.